Dr. Venetia Zachariou's lab at Boston University Medical Campus focuses on understanding chronic pain mechanisms, specifically looking at a protein called RGS4 that influences nerve signals. By studying how RGS4 functions in different types of nerve cells, the lab aims to identify new targets for pain management, potentially leading to safer and more effective treatments for people suffering from neuropathic pain.

Dr. Hui Feng's lab studies neuroblastoma, a type of cancer that affects children, particularly focusing on how certain proteins influence immune responses in tumors. They investigate how MYCN, a gene often associated with cancer aggressiveness, contributes to a hostile tumor microenvironment that suppresses the immune system. By understanding these mechanisms, the team aims to develop better immunotherapy strategies to fight neuroblastoma and possibly other cancers.

Dr. Zhen Yue Jiang's lab at Boston University Medical Campus focuses on understanding how neutrophils contribute to vascular aging and related diseases. They explore the role of neutrophil elastase, a key protein involved in inflammation, and how it influences arterial stiffness and cardiovascular health as we age. The research aims to unravel the molecular mechanisms behind these processes and develop potential new treatments to combat age-related vascular issues.

Dr. Shelley J Russek's lab studies how specific signaling pathways in the brain contribute to epilepsy, particularly temporal lobe epilepsy (TLE). By examining excitatory neurons in mouse models, they aim to understand how these pathways affect brain inflammation and neuronal function, which could lead to new treatments for TLE. Their research combines various techniques to explore the interactions between genes, brain cells, and potential therapies.

Dr. Julia Tcw's lab at Boston University Medical Campus focuses on understanding the cellular mechanisms of Alzheimer's disease, especially as they relate to two critical components: astrocytes and microglia, which are types of brain cells. The lab investigates how genetic factors like the APOE4 variant affect cellular processes that lead to neurodegeneration. By studying human brain cells in the lab, they aim to identify new potential treatments for Alzheimer's disease, particularly by targeting the dysfunctions in brain cell nutrient processing and inflammation.

Dr. Weiming Xia's lab at Boston University focuses on finding new treatments for Alzheimer's disease (AD) by analyzing large datasets from veterans' health records. The lab investigates how certain medications, particularly vasodilators, may slow the progression of AD and alleviate cognitive impairments. By combining big data analysis with experiments in mouse models, the lab aims to uncover potential therapies that can be quickly developed for patients.